233 related articles for article (PubMed ID: 18706292)
1. Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents.
Glickson JD; Lund-Katz S; Zhou R; Choi H; Chen IW; Li H; Corbin I; Popov AV; Cao W; Song L; Qi C; Marotta D; Nelson DS; Chen J; Chance B; Zheng G
Mol Imaging; 2008; 7(2):101-10. PubMed ID: 18706292
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agents.
Glickson JD; Lund-Katz S; Zhou R; Choi H; Chen IW; Li H; Corbin I; Popov AV; Cao W; Song L; Qi C; Marotta D; Nelson DS; Chen J; Chance B; Zheng G
Adv Exp Med Biol; 2009; 645():227-39. PubMed ID: 19227476
[TBL] [Abstract][Full Text] [Related]
3. MR and fluorescent imaging of low-density lipoprotein receptors.
Li H; Gray BD; Corbin I; Lebherz C; Choi H; Lund-Katz S; Wilson JM; Glickson JD; Zhou R
Acad Radiol; 2004 Nov; 11(11):1251-9. PubMed ID: 15561572
[TBL] [Abstract][Full Text] [Related]
4. Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme.
Nikanjam M; Gibbs AR; Hunt CA; Budinger TF; Forte TM
J Control Release; 2007 Dec; 124(3):163-71. PubMed ID: 17964677
[TBL] [Abstract][Full Text] [Related]
5. Synthetic nano-low density lipoprotein as targeted drug delivery vehicle for glioblastoma multiforme.
Nikanjam M; Blakely EA; Bjornstad KA; Shu X; Budinger TF; Forte TM
Int J Pharm; 2007 Jan; 328(1):86-94. PubMed ID: 16959446
[TBL] [Abstract][Full Text] [Related]
6. Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents.
Zheng G; Chen J; Li H; Glickson JD
Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17757-62. PubMed ID: 16306263
[TBL] [Abstract][Full Text] [Related]
7. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
[TBL] [Abstract][Full Text] [Related]
8. Uptake of low-density lipoprotein by malignant cells--possible therapeutic applications.
Vitols S
Cancer Cells; 1991 Dec; 3(12):488-95. PubMed ID: 1840290
[TBL] [Abstract][Full Text] [Related]
9. Cell-penetrating peptides and peptide nucleic acid-coupled MRI contrast agents: evaluation of cellular delivery and target binding.
Mishra R; Su W; Pohmann R; Pfeuffer J; Sauer MG; Ugurbil K; Engelmann J
Bioconjug Chem; 2009 Oct; 20(10):1860-8. PubMed ID: 19788302
[TBL] [Abstract][Full Text] [Related]
10. Photosensitizer-conjugated magnetic nanoparticles for in vivo simultaneous magnetofluorescent imaging and targeting therapy.
Huang P; Li Z; Lin J; Yang D; Gao G; Xu C; Bao L; Zhang C; Wang K; Song H; Hu H; Cui D
Biomaterials; 2011 May; 32(13):3447-58. PubMed ID: 21303717
[TBL] [Abstract][Full Text] [Related]
11. A multimodal magnetic resonance imaging nanoplatform for cancer theranostics.
Benyettou F; Lalatonne Y; Chebbi I; Di Benedetto M; Serfaty JM; Lecouvey M; Motte L
Phys Chem Chem Phys; 2011 Jun; 13(21):10020-7. PubMed ID: 21409252
[TBL] [Abstract][Full Text] [Related]
12. Effects of isoxazolidine or triazolidine on rat serum lipids in vivo and LDL and HDL binding and degradation in human and rodent cultured cells in vitro.
Hall IH; Wong OT; Simlot R; Izydore RA
Res Commun Chem Pathol Pharmacol; 1992 Sep; 77(3):327-46. PubMed ID: 1333628
[TBL] [Abstract][Full Text] [Related]
13. Low-density lipoprotein nanoparticles as magnetic resonance imaging contrast agents.
Corbin IR; Li H; Chen J; Lund-Katz S; Zhou R; Glickson JD; Zheng G
Neoplasia; 2006 Jun; 8(6):488-98. PubMed ID: 16820095
[TBL] [Abstract][Full Text] [Related]
14. Structure of triglyceride-rich human low-density lipoproteins according to cryoelectron microscopy.
Sherman MB; Orlova EV; Decker GL; Chiu W; Pownall HJ
Biochemistry; 2003 Dec; 42(50):14988-93. PubMed ID: 14674775
[TBL] [Abstract][Full Text] [Related]
15. Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles.
Schroeder JE; Shweky I; Shmeeda H; Banin U; Gabizon A
J Control Release; 2007 Dec; 124(1-2):28-34. PubMed ID: 17928088
[TBL] [Abstract][Full Text] [Related]
16. Cytosolic delivery of LDL nanoparticle cargo using photochemical internalization.
Jin H; Lovell JF; Chen J; Ng K; Cao W; Ding L; Zhang Z; Zheng G
Photochem Photobiol Sci; 2011 May; 10(5):810-6. PubMed ID: 21344108
[TBL] [Abstract][Full Text] [Related]
17. Folate-targeted chemotherapy.
Leamon CP; Reddy JA
Adv Drug Deliv Rev; 2004 Apr; 56(8):1127-41. PubMed ID: 15094211
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of selective cholesteryl ester uptake pathway in mice with deletion of low-density lipoprotein receptor function.
Azhar S; Luo Y; Medicherla S; Reaven E
J Cell Physiol; 1999 Aug; 180(2):190-202. PubMed ID: 10395289
[TBL] [Abstract][Full Text] [Related]
19. Preparation of drug-low density lipoprotein complexes for delivery of antitumoral drugs via the low density lipoprotein pathway.
Lundberg B
Cancer Res; 1987 Aug; 47(15):4105-8. PubMed ID: 3607752
[TBL] [Abstract][Full Text] [Related]
20. Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs.
Lacko AG; Nair M; Prokai L; McConathy WJ
Expert Opin Drug Deliv; 2007 Nov; 4(6):665-75. PubMed ID: 17970668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
